TABLOID
TABLOID brand Thioguanine 40-mg Scored Tablets
Approved
Approval ID
44b0c461-47fb-4106-ba11-6ed85530235c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
May 16, 2023
Manufacturers
FDA
Waylis Therapeutics LLC
DUNS: 117678921
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
thioguanine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code80725-630
Application NumberNDA012429
Product Classification
M
Marketing Category
C73594
G
Generic Name
thioguanine
Product Specifications
Route of AdministrationORAL
Effective DateMay 15, 2023
FDA Product Classification
INGREDIENTS (6)
THIOGUANINEActive
Quantity: 40 mg in 1 1
Code: FTK8U1GZNX
Classification: ACTIB
ACACIAInactive
Code: 5C5403N26O
Classification: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
STARCH, POTATOInactive
Code: 8I089SAH3T
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT